Celularity Inc.
Celularity Inc. (CELU) Revenue
Annual & quarterly revenue history · segment & region breakdown
CELU · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCelularity Inc. trailing twelve-month (TTM) revenue is $0.03B, a decrease of 51.03% year-over-year from $0.03B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.03B | -$0.03B | -51.03% |
| 2024-12-31 | $0.05B | +$0.03B | +138.11% |
| 2023-12-31 | $0.02B | +$0.00B | +26.68% |
| 2022-12-31 | $0.02B | -$0.00B | -15.75% |
| 2021-12-31 | $0.02B | +$0.01B | +49.43% |
| 2020-12-31 | $0.01B | -$0.01B | -32.48% |
| 2019-12-31 | $0.02B | +$0.00B | +20.47% |
| 2018-12-31 | $0.02B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Celularity Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Celularity Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Celularity Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CELU revenue · 4 questionsCELU's trailing twelve-month (TTM) revenue is $0.03B. That is a decrease of 51.03% year-over-year from $0.03B in FY2025.
▸ Source: FMP · Celularity Inc. SEC filings · GAAP · Celularity Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026